|
(BS303) |
Role of endothelin-1 in HFpEF-related ventricular and atrial remodeling |
| |
|
D. Bode, P. Deissler, F. Schönrath, S. Soltani, C. Stamm, V. Düsterhöft, C. Knosalla, V. Falk, B. Pieske, F. R. Heinzel, F. Hohendanner (Berlin) |
|
(BS304) |
Preventing PKG1a Oxidation on Cysteine 42 can antagonize mTORC1 to enhance Autophagy and to ameliorate Cardiac Disease |
| |
|
C. Oeing, B. Dunkerly-Eyring, B. Pieske, D. Kass, M. Ranek (Berlin; Baltimore, US) |
|
(BS305) |
Proof of principle and preclinical development of a novel epigenetic heart failure therapy |
| |
|
M. Dewenter, A. von der Lieth, T. He, L. Chen, J. Beckendorf, J. Lewis, M. Hrabe de Angelis, W.-H. Zimmermann, B. Klebl, H. A. Katus, J. Backs (Heidelberg, München, Göttingen, Dortmund) |
|
(BS306) |
Cell type-specific effects of miR-21 in the mammalian heart |
| |
|
C. Beck, D. Ramanujam, J. Kerler, A. P. Schön, S. Engelhardt (München) |
|
(BS307) |
Sepsis-induced acute heart failure is driven by MEF2D-dependent transcription |
| |
|
F. Alban, R. Schell, C. Haslinger, P. Theis, H. A. Katus, J. Backs (Heidelberg) |
|
(BS308) |
CaM Kinase II-dependent phosphorylation of histone H3S28 regulates cardiac hemoglobin upon sympathetic activation |
| |
|
A. R. Saadatmand, V. Sramek, D. Finke, M. Dewenter, C. Sticht, L. H. Lehmann, A. El-Armouche, J. Backs, für die Studiengruppe: DZHK (Heidelberg, Mannheim, Dresden) |
|
(BS309) |
Enhanced cardiac exercise in a marathon runners cohort alters plasma profiles of circular RNAs |
| |
|
A. Meinecke, F. Mooren, J. Fiedler, T. Thum (Hannover, Witten) |
|
(BS310) |
The role of the nuclear envelope protein LEMD2 in the development of cardiomyopathy in mice and human |
| |
|
R. Chen, N. Abdelfatah, P. Gordon, A. Nickel, M. Regensburger, T. Williams, A.-P. Arias-Loza, C. Maack, B. Gerull (Würzburg, Calgary) |